IDEX Biometrics ASA engages in the design, development, and sale of fingerprint identification and authentication solutions in Europe, the Middle East, Africa, the Americas, and Asia.
IDEX Biometrics Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||kr2.53|
|52 Week High||kr1.55|
|52 Week Low||kr3.50|
|1 Month Change||3.86%|
|3 Month Change||20.36%|
|1 Year Change||22.82%|
|3 Year Change||-64.66%|
|5 Year Change||-67.36%|
|Change since IPO||-99.40%|
Recent News & Updates
|IDEX||NO Electronic||NO Market|
Return vs Industry: IDEX underperformed the Norwegian Electronic industry which returned 32.9% over the past year.
Return vs Market: IDEX underperformed the Norwegian Market which returned 26.4% over the past year.
Stable Share Price: IDEX is more volatile than 75% of Norwegian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: IDEX's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
IDEX Biometrics ASA engages in the design, development, and sale of fingerprint identification and authentication solutions in Europe, the Middle East, Africa, the Americas, and Asia. The company offers IDEX Biometrics for the biometrics smart card market, including biometric fingerprint sensors for use in dual interface, contactless only, and contact only smart cards; biometric fingerprint modules for contact based smart cards; and on-card enrollment solutions for remote in-person enrollment. It primarily serves biometric payment card market, as well as offers its products and solutions for other markets, including access control, identification, healthcare, and the Internet of Things.
IDEX Biometrics Fundamentals Summary
|IDEX fundamental statistics|
Is IDEX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IDEX income statement (TTM)|
|Cost of Revenue||US$748.00k|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Nov 04, 2021
|Earnings per share (EPS)||-0.031|
|Net Profit Margin||-1,329.21%|
How did IDEX perform over the long term?See historical performance and comparison
Is IDEX Biometrics undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate IDEX's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate IDEX's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: IDEX is unprofitable, so we can't compare its PE Ratio to the European Electronic industry average.
PE vs Market: IDEX is unprofitable, so we can't compare its PE Ratio to the Norwegian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IDEX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IDEX is overvalued based on its PB Ratio (10.8x) compared to the NO Electronic industry average (3.9x).
How is IDEX Biometrics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IDEX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IDEX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IDEX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IDEX's revenue (135.6% per year) is forecast to grow faster than the Norwegian market (5.6% per year).
High Growth Revenue: IDEX's revenue (135.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IDEX's Return on Equity is forecast to be high in 3 years time
How has IDEX Biometrics performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IDEX is currently unprofitable.
Growing Profit Margin: IDEX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: IDEX is unprofitable, and losses have increased over the past 5 years at a rate of 1.4% per year.
Accelerating Growth: Unable to compare IDEX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IDEX is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (30.6%).
Return on Equity
High ROE: IDEX has a negative Return on Equity (-115.11%), as it is currently unprofitable.
How is IDEX Biometrics's financial position?
Financial Position Analysis
Short Term Liabilities: IDEX's short term assets ($22.9M) exceed its short term liabilities ($3.2M).
Long Term Liabilities: IDEX's short term assets ($22.9M) exceed its long term liabilities ($150.0K).
Debt to Equity History and Analysis
Debt Level: IDEX is debt free.
Reducing Debt: IDEX has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IDEX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: IDEX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 0.5% each year
What is IDEX Biometrics's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IDEX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IDEX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IDEX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IDEX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IDEX's dividend in 3 years as they are not forecast to pay a notable one for the Norwegian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Vince Graziani (60 yo)
Mr. Vincent Graziani, also known as Vince, had been Chief Executive Officer of Sand 9 Inc. since February 2010 until May 2015 and served as its President. Mr. Graziani serves as Chief Executive Officer at...
CEO Compensation Analysis
Compensation vs Market: Vince's total compensation ($USD455.00K) is about average for companies of similar size in the Norwegian market ($USD544.80K).
Compensation vs Earnings: Insufficient data to compare Vince's compensation with company performance.
Experienced Management: IDEX's management team is considered experienced (2.5 years average tenure).
Experienced Board: IDEX's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.7%.
IDEX Biometrics ASA's employee growth, exchange listings and data sources
- Name: IDEX Biometrics ASA
- Ticker: IDEX
- Exchange: OB
- Founded: 1996
- Industry: Electronic Components
- Sector: Tech
- Market Cap: kr2.326b
- Shares outstanding: 919.51m
- Website: https://www.idexbiometrics.com
Number of Employees
- IDEX Biometrics ASA
- Dronning Eufemias gate 16
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/27 21:20|
|End of Day Share Price||2021/09/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.